Therapeutic resistance

1 paper

Animals1

Latest

26 in 12 months

Cancer Reports13 Sep

A Review of Senescence-Associated Secretory Phenotype-Mediated Remodeling of the Tumor Microenvironment: Implications for Cancer Progression and Therapy

ReviewSenescence-associated secretory phenotype (SASP)

Frontiers in Cell and Developmental Biology27 Aug

Mitochondrial regulation of cellular senescence heterogeneity

ReviewCellular senescence

Frontiers in Oncology22 Aug

Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions

ReviewMechanisms

Cell Biochemistry and Function18 Aug

TET2 as a Context-Dependent Epigenetic Integrator in Clonal Hematopoiesis, Inflammation, Cancer, and Immunotherapy

ReviewInflammation

Cancer Medicine11 Aug

Clonal Hematopoiesis in Colorectal Cancer: Mechanisms and Implications

ReviewBlood and immune system

Nature Communications22 Jul

Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy

Experiments in miceCancer

Inflammopharmacology21 Jul

Natural products targeting cytokine-regulated SASP inflammation networks in Ovarian cancer: Implications on immune escape and molecular resistance

ReviewInterventions

bioRxiv16 Jul

High glucose confers senescence resistance via GLUT1 epigenetic rewiring to blunt immunotherapy responses in esophageal squamous cell carcinoma

Preprint: experiments in animalsMechanisms

Frontiers in Immunology18 May

Unraveling immunological heterogeneity in recalcitrant AIH-PBC/PSC overlap syndromes: from molecular crosstalk to precision therapeutics

ReviewMechanisms

Virchows Archiv6 May

Integrated biomarker mapping reveals differential expression of senescence profiles in IDH-wild-type glioblastoma recurrent versus primary tumors

Study in peopleMechanisms